Workflow enables diverse microbiome research applications, including gut health, soil microbiology, and antibiotic resistance, maximizing DNA diversity and minimizing bias.
The molecular diagnostics (MDx) market is estimated to be worth $16.6B in 2023, and expected to reach $28.6B by 2028, as “Rapid progress in technologies such as next-generation...
PGx can lead to better overall quality of care by making sure that medications are prescribed with the specific individual in mind rather than guessing what may work best under...
Doctors may be able to target these genes with existing medications – or possibly even nutritional supplements – to slow or halt the disease’s progression.